Search - Université de Rennes Access content directly

Filter your results

28 Results
Author: personID (integer) : 862464

Reduction of extended-release tacrolimus dose in low immunological risk kidney transplant recipients increases risk of rejection and appearance of DSA - a randomized study

Philippe Gatault , Nassim Kamar , Matthias Buchler , Charlotte Colosio , Dominique Bertrand et al.
American Journal of Transplantation, 2016
Journal articles hal-01400266v1

No evidence of hepatitis B virus reactivation among liver transplant recipients treated with interferon- free regimens for hepatitis C virus recurrence (ANRS CO23 CUPILT Cohort)

Lina Mouna , Emilie Rossignol , Mariagrazia Tateo , Jean-Charles Duclos-Vallee , Christophe Duvoux et al.
Hepatology, 2017, 66, pp.873A-874A
Journal articles hal-01769634v1

G15 : The association of sofosbuvir and daclatasvir for treating severe recurrence of HCV infection after liver transplantation: Results from a large french prospective multicentric ANRS CO23 CUPILT cohort

A. Coilly , C. Fougerou , V. de Ledinghen , P. Houssel-Debry , C. Duvoux et al.
The International Liver Congress™ 2015 – 50th Annual meeting of the European Association for the Study of the Liver, Apr 2015, Vienne, Austria. pp.S236--S237, ⟨10.1016/S0168-8278(15)30103-3⟩
Conference papers hal-01162709v1

Long term results of liver transplantation for Wilson's disease: experience in France

Olivier Guillaud , Jérôme Dumortier , Rodolphe Sobesky , Dominique Debray , Philippe Wolf et al.
Journal of Hepatology, 2014, 60 (3), pp.579--589. ⟨10.1016/j.jhep.2013.10.025⟩
Journal articles hal-01068685v1
Image document

Direct-acting antiviral agent-based regimen for HCV recurrence after combined liver-kidney transplantation: Results from the ANRS CO23 CUPILT study

Sébastien Dharancy , Audrey Coilly , Claire Fougerou-Leurent , Christophe Duvoux , Nassim Kamar et al.
American Journal of Transplantation, 2017, 17 (11), pp.2869-2878. ⟨10.1111/ajt.14490⟩
Journal articles hal-01640061v1
Image document

Efficacy and Safety of Everolimus and Mycophenolic Acid With Early Tacrolimus Withdrawal After Liver Transplantation: A Multicenter Randomized Trial

Faouzi Saliba , Christophe Duvoux , Jean Gugenheim , Nassim Kamar , Sébastien Dharancy et al.
American Journal of Transplantation, 2017, 17 (7), pp.1843-1852. ⟨10.1111/ajt.14212⟩
Journal articles hal-01558819v1

Hepatitis B virus reactivation in transplant patients treated for hepatitis C recurrence Prophylaxis makes the difference

Lina Mouna , Emilie Rossignol , Mariagrazia Tateo , Audrey Coilly , Jean-Charles Duclos-Vallee et al.
Journal of Hepatology, 2019, 70 (6), pp.1297-1300. ⟨10.1016/j.jhep.2019.02.019⟩
Journal articles hal-02120675v1

Multicentre experience using daclatasvir and sofosbuvir to treat hepatitis C recurrence - The ANRS CUPILT study

Audrey Coilly , Claire Fougerou-Leurent , Victor De Ledinghen , Pauline Houssel-Debry , Christophe Duvoux et al.
Journal of Hepatology, 2016, 65 (4), pp.711--718. ⟨10.1016/j.jhep.2016.05.039⟩
Journal articles hal-01395132v1
Image document

An initial report from the French SOT COVID Registry suggests high mortality due to Covid-19 in recipients of kidney transplants

Sophie Caillard , Dany Anglicheau , Marie Matignon , Antoine Dürrbach , Clarisse Greze et al.
Kidney International, 2020, 98 (6), pp.1549-1558. ⟨10.1016/j.kint.2020.08.005⟩
Journal articles hal-02930165v1

Impact of the New MELD-based Allocation System on Waiting List and Post-Transplant Survival - A Cohort Analysis Using the French National CRISTAL Database

Carine Jasseron , Claire Francoz , Corinne Antoine , Camille Legeai , François Durand et al.
Transplant International, 2019, 32 (10), pp.1061--1073. ⟨10.1111/tri.13448⟩
Journal articles hal-02862291v1
Image document

Is COVID‐19 infection more severe in kidney transplant recipients?

Sophie Caillard , Nathalie Chavarot , Hélène Francois , Marie Matignon , Clarisse Greze et al.
American Journal of Transplantation, 2021, 21 (3), pp.1295-1303. ⟨10.1111/ajt.16424⟩
Journal articles hal-03371189v1
Image document

Clinical utility of biochemical markers for the prediction of COVID-19-related mortality in kidney transplant recipients

Sophie Caillard , Nathalie Chavarot , Helene Francois , Marie Matignon , Renaud Snanoudj et al.
Kidney International Reports, 2021, 6 (10), pp.2689-2693. ⟨10.1016/j.ekir.2021.06.034⟩
Journal articles hal-03333553v2
Image document

Sofosbuvir-based treatment of hepatitis C with severe fibrosis (METAVIR F3/F4) after liver transplantation results from the CO23 ANRS CUPILT study

Jerome Dumortier , V. Leroy , C. Duvoux , V. De Lédinghen , C. Francoz et al.
Liver Transplantation, 2016, 22 (10), pp.1367--1378. ⟨10.1002/lt.24505⟩
Journal articles hal-01397762v1
Image document

The FcγRIIIA-158 VV genotype increased the risk of post-transplant lymphoproliferative disorder in T-cell-depleted kidney transplant recipients – a retrospective study

P. Gatault , L. Lajoie , J. Stojanova , J.-M. Halimi , S. Caillard et al.
Transplant International, In press, ⟨10.1111/tri.13624⟩
Journal articles hal-02638433v1

O109 : Treatment of severe HCV-recurrence after liver transplantation using sofosbuvir-based regimens: The ANRS CO23 CUPILT study

J. Dumortier , D. Botta-Fridlund , A. Coilly , V. Leroy , C. Fougerou-Leurent et al.
The International Liver Congress™ 2015 – 50th Annual meeting of the European Association for the Study of the Liver, Apr 2015, Vienne, Austria. pp.S247--S248, ⟨10.1016/S0168-8278(15)30128-8⟩
Conference papers hal-01162706v1

Comparison of the effect of direct-acting antiviral with and without ribavirin on cyclosporine and tacrolimus clearance values results from the ANRS CO23 CUPILT cohort

Aurélie Barrail-Tran , Lauriane Goldwirt , Thibaut Gelé , Claire Laforest , Audrey Lavenu et al.
European Journal of Clinical Pharmacology, 2019, 75 (11), pp.1555-1563. ⟨10.1007/s00228-019-02725-x⟩
Journal articles hal-02280498v1

Efficacy of Sofosbuvir and Daclatasvir in Patients with Fibrosing Cholestatic Hepatitis C After Liver Transplantation

Vincent Leroy , Jérôme Dumortier , Audrey Coilly , Mylène Sebagh , Claire Fougerou-Leurent et al.
Clinical Gastroenterology and Hepatology, 2015, 13 (11), pp.1993-2001.e2. ⟨10.1016/j.cgh.2015.05.030⟩
Journal articles hal-01162384v1
Image document

Belatacept as maintenance therapy in kidney transplant recipients with ANCA-associated vasculitis

Manon Martins , Antoine Morel , Charlotte Laurent , Nassim Kamar , Dany Anglicheau et al.
Clinical and experimental rheumatology, 2021
Journal articles hal-03216600v1
Image document

Microsporidiosis after liver transplantation: A French nationwide retrospective study

Jérôme Dumortier , Sylvie Radenne , Nassim Kamar , Filomena Conti , Armand Abergel et al.
Transplant Infectious Disease, 2021, pp.e13665. ⟨10.1111/tid.13665⟩
Journal articles hal-03280899v1

Sofosbuvir-Based Regimens in HIV/HCV Coinfected Patients after Liver Transplantation: Results from the ANRS CO23 CUPILT Study

T.M. Antonini , A. Coilly , E. Rossignol , C. Fougerou-Leurent , J. Dumortier et al.
Transplantation, 2018, 102 (1), pp.119-126. ⟨10.1097/TP.0000000000001928⟩
Journal articles hal-01685801v1

Should we keep using Ribavirin to Treat Hepatitis C Recurrence after Liver Transplantation? Results from the CO23 ANRS Cupilt Study

P. Houssel-Debry , C. Duvoux , A. Coilly , C. Fougerou-Leurent , C. Jezequel et al.
Journal of Hepatology, 2016, 64 (2), pp.S144--S145. ⟨10.1016/S0168-8278(16)01652-4⟩
Journal articles hal-01533345v1
Image document

Kidney transplantation improves the clinical outcomes of Acute Intermittent Porphyria

Hélène Lazareth , Neila Talbi , Nassim Kamar , Charlène Levi , Bruno Moulin et al.
Molecular Genetics and Metabolism, 2020, 131 (1-2), pp.259-266. ⟨10.1016/j.ymgme.2020.08.004⟩
Journal articles hal-02959719v1

P0804 : Efficacy of sofosbuvir-based treatment regimens in HIV/HCV co-infected patients after liver transplantation: The ANRS CO23 CUPILT study

T. M. Antonini , A. Coilly , S. Radenne , A. Veislinger , D. Botta-Fridlund et al.
The International Liver Congress™ 2015 – 50th Annual meeting of the European Association for the Study of the Liver, Apr 2015, Vienne, Austria. 62, Supplement 2, pp.S635--S636, 2015, ⟨10.1016/S0168-8278(15)31007-2⟩
Conference poster hal-01162778v1

Sofosbuvir and NS5A inhibitors without Ribavirin during 12 weeks are efficient to treat hepatitis C recurrence after liver transplantation only in genotype 1. Results from the CO23 ANRS CUPILT study.

Pauline Houssel-Debry , Audrey Coilly , Claire Fougerou-Leurent , Caroline Jezequel , Christophe Duvoux et al.
Hepatology, 2017, 63 (1 SUPP), pp.465A--465A
Journal articles hal-01412958v1

12 weeks of a Ribavirin-free Sofosbuvir and NS5A inhibitor regimen is enough to treat recurrence of hepatitis C after liver transplantation

Pauline Houssel-Debry , Audrey Coilly , Claire Fougerou-Leurent , Caroline Jezequel , Christophe Duvoux et al.
Hepatology, 2018, 68 (4), pp.1277-1287. ⟨10.1002/hep.29918⟩
Journal articles hal-01807755v1
Image document

Cryptococcal Meningitis in Kidney Transplant Recipients: A Two-Decade Cohort Study in France

Laurène Tardieu , Gillian Divard , Olivier Lortholary , Anne Scemla , Éric Rondeau et al.
Pathogens, 2022, 11 (6), pp.699. ⟨10.3390/pathogens11060699⟩
Journal articles hal-03789427v1

Post-transplantation lymphoproliferative disorder after kidney transplantation: report of a nationwide French registry and the development of a new prognostic score.

Sophie Caillard , Raphael Porcher , François Provot , Jacques Dantal , Sylvain Choquet et al.
Journal of Clinical Oncology, 2013, 31 (10), pp.1302-9. ⟨10.1200/JCO.2012.43.2344⟩
Journal articles inserm-00925169v1

QuiPO : qui administre les EPO en prédialyse ?

Cécile Vigneau , Sylvie Le Stum , Corinne Isnard-Bagnis , Gabriel Choukroun , Yannick Lemeur et al.
Néphrologie & Thérapeutique, 2014, 10 (7), pp.507-11. ⟨10.1016/j.nephro.2014.06.003⟩
Journal articles hal-01120366v1